semaglutide mash pdufa Emerging Role of GLP-1 Receptor Agonists for the Treatment of Semaglutide May Reduce Liver Fibrosis

ACPE UANs Pharmacist: 0009-0000-26-003-H01-P Pharmacy Technician: 0009-0000-26-003-H01-T Session Codes Pharmacist: 26YC03-BQK21 Pharmacy Technician: 26YC03-KQB12 Accreditation Hours 2.0 hours of CE Accreditation Statements Disclosure of Discussions of Off-label and Investigational Drug Use The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates

Jordan Tucker, DDS, and Dr

Because of their oral administration, there are some instances when the use of DPP-4 inhibitors is preferable

Combining GLP-1 and GIP actions, as seen in newer treatments, leverages the benefits of both for more effective diabetes management and weight loss.